01 Oct 2021
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
Sponsored by Terumo
Summary
In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.